Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Osteonecrosis × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3 Lymphoid 3 Sarcoma 1 Plasma cell 1 Classical hematology 1

Conditions

Multiple Myeloma 1470 Neoplasms, Plasma Cell 362 Lymphoma, Non-Hodgkin 275 Lymphoma 250 Hodgkin Disease 244 Leukemia, Lymphocytic, Chronic, B-Cell 236 Precursor Cell Lymphoblastic Leukemia-Lymphoma 208 Leukemia 194 Leukemia, Myeloid, Acute 190 Myelodysplastic Syndromes 170 Lymphoma, Mantle-Cell 168 Lymphoma, Follicular 167 Lymphoma, Large B-Cell, Diffuse 166 Recurrence 162 Lymphoma, B-Cell, Marginal Zone 149 Burkitt Lymphoma 146 Lymphoma, Large-Cell, Immunoblastic 139 Myeloproliferative Disorders 129 Leukemia, Myeloid, Chronic-Phase 112 Primary Myelofibrosis 106 Leukemia, Myeloid, Accelerated Phase 104 Lymphoma, T-Cell, Cutaneous 103 Immunoglobulin Light-chain Amyloidosis 103 Blast Crisis 99 Waldenstrom Macroglobulinemia 97 Leukemia, Myelomonocytic, Chronic 92 Sezary Syndrome 84 Neoplasms 84 Mycosis Fungoides 84 Leukemia, Hairy Cell 84

Interventions

Zoledronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02286830 2023-02-17

Magnolia

Odense University Hospital

Phase 4 Completed

Multiple Myeloma, Osteolysis, Osteonecrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡